Ilyang Pharmaceutical Co.,Ltd (KRX:007570)
South Korea
· Delayed Price · Currency is KRW 11,380
0.00 (0.00%)
Last updated: Apr 29, 2026, 2:00 PM KST
KRX:007570 Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 203,986 | 233,921 | 205,533 | 281,258 | 349,981 | 510,655 | Upgrade
|
| Market Cap Growth | -13.49% | 13.81% | -26.92% | -19.64% | -31.46% | -57.37% | Upgrade
|
| Enterprise Value | 306,072 | 341,842 | 341,070 | 394,941 | 436,337 | 605,360 | Upgrade
|
| Last Close Price | 11380.00 | 12895.00 | 11274.48 | 15257.93 | 18681.48 | 26877.80 | Upgrade
|
| PE Ratio | 30.35 | 33.88 | 22.76 | - | 18.49 | 36.39 | Upgrade
|
| Forward PE | - | 49.90 | 49.90 | 49.90 | 49.90 | 49.90 | Upgrade
|
| PS Ratio | 0.75 | 0.86 | 0.77 | 1.06 | 1.41 | 2.11 | Upgrade
|
| PB Ratio | 0.84 | 0.97 | 0.86 | 1.22 | 1.47 | 2.25 | Upgrade
|
| P/TBV Ratio | 0.87 | 1.00 | 0.88 | 1.26 | 1.51 | 2.32 | Upgrade
|
| P/FCF Ratio | 32.26 | 36.99 | - | 32.19 | 180.62 | 13.07 | Upgrade
|
| P/OCF Ratio | 16.94 | 19.43 | 36.60 | 19.24 | 59.49 | 9.93 | Upgrade
|
| EV/Sales Ratio | 1.12 | 1.25 | 1.27 | 1.48 | 1.76 | 2.50 | Upgrade
|
| EV/EBITDA Ratio | 24.56 | 25.69 | 17.54 | 13.93 | 16.77 | 22.92 | Upgrade
|
| EV/EBIT Ratio | 74.31 | 68.88 | 35.45 | 24.11 | 30.62 | 39.86 | Upgrade
|
| EV/FCF Ratio | 48.40 | 54.06 | - | 45.21 | 225.19 | 15.50 | Upgrade
|
| Debt / Equity Ratio | 0.53 | 0.53 | 0.45 | 0.32 | 0.31 | 0.43 | Upgrade
|
| Debt / EBITDA Ratio | 9.53 | 9.53 | 5.54 | 2.56 | 2.85 | 3.73 | Upgrade
|
| Debt / FCF Ratio | 20.05 | 20.05 | - | 8.32 | 38.24 | 2.52 | Upgrade
|
| Net Debt / Equity Ratio | 0.40 | 0.40 | 0.40 | 0.26 | 0.26 | 0.24 | Upgrade
|
| Net Debt / EBITDA Ratio | 7.30 | 7.30 | 4.88 | 2.08 | 2.36 | 2.08 | Upgrade
|
| Net Debt / FCF Ratio | 15.37 | 15.37 | -2.91 | 6.75 | 31.75 | 1.41 | Upgrade
|
| Asset Turnover | 0.61 | 0.61 | 0.65 | 0.67 | 0.60 | 0.56 | Upgrade
|
| Inventory Turnover | 2.52 | 2.52 | 2.79 | 2.96 | 3.46 | 3.40 | Upgrade
|
| Quick Ratio | 0.46 | 0.46 | 0.39 | 0.47 | 0.46 | 0.59 | Upgrade
|
| Current Ratio | 0.86 | 0.86 | 0.80 | 0.89 | 0.82 | 0.81 | Upgrade
|
| Return on Equity (ROE) | 2.97% | 2.97% | 3.95% | -0.87% | 8.53% | 6.25% | Upgrade
|
| Return on Assets (ROA) | 0.70% | 0.70% | 1.46% | 2.57% | 2.17% | 2.21% | Upgrade
|
| Return on Invested Capital (ROIC) | 0.77% | 0.79% | 2.63% | 5.56% | 4.07% | 3.45% | Upgrade
|
| Return on Capital Employed (ROCE) | 1.70% | 1.70% | 3.50% | 6.50% | 5.50% | 6.00% | Upgrade
|
| Earnings Yield | 3.38% | 2.95% | 4.39% | -0.86% | 5.54% | 2.75% | Upgrade
|
| FCF Yield | 3.10% | 2.70% | -15.85% | 3.11% | 0.55% | 7.65% | Upgrade
|
| Dividend Yield | 1.36% | - | - | 0.98% | - | - | Upgrade
|
| Payout Ratio | 41.72% | 41.72% | 32.93% | - | 20.34% | 16.74% | Upgrade
|
| Buyback Yield / Dilution | 0.11% | 0.11% | -2.29% | 0.59% | 0.44% | - | Upgrade
|
| Total Shareholder Return | 1.44% | 0.11% | -2.29% | 1.57% | 0.44% | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.